Orchid Pharma share news and announcements
NSE: ORCHPHARMABSE: 524372Pharmaceuticals & BiotechnologySmall Cap
Formerly Orchid Chemicals & Pharmaceuticals
Last close ₹823.30down ₹52.25 (5.97%)BSE ₹826.10
Share price at the NSE close on 23 Oct 2026. Previous close ₹875.55.
52-week range of traded prices to 23 Oct 2026
₹480.00Low, 30 Mar 2026₹1,143.50High, 22 Sep 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹4,930 Cr919th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit.
- Earlier quarters restated in the year
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet.
- Shares changed
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 14 Aug 2026
- 0.2%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 14 Aug 2026
- 0.19
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 1,70,48053.5% delivered
Orchid Pharma routine notices
82 filed, newest first. Page 2 of 2.
Jun 2022
30 Jun · Routine
May 2022
Mar 2022
31 Mar · Routine
Feb 2022
Jan 2022
Dec 2021
Nov 2021
Oct 2021
Sep 2021
29 Sep · Routine
Aug 2021
17 Aug · Routine
Jul 2021
23 Jul · Routine
Jun 2021
Apr 2021
Mar 2021
Feb 2021
4 Feb · Routine
Jan 2021
Dec 2020
Nov 2020
Oct 2020
Sep 2020
Jul 2020
Apr 2020
1 Apr · Routine
May 2016